Stocktwits on MSN
Assembly Biosciences stock jumps after Wall Street says Gilead opt-in 'significantly de-risks' genital herpes programs
Gilead will advance the clinical development and commercialization of the programs and Assembly Bio will receive a $35 ...
Gilead (GILD) and Assembly Biosciences (ASMB), announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback